3D Bioprinting Solutions

Organ.Aut — Magnetic levitational bioassembly, nozzle-free.

Country
RU
Coverage
CNEUUS
cross-sector-intersections✓✓✓
Regulatorsfdafaa

Verifiable facts

FactValueSource
AffiliationFounded by INVITRO (a private medical company); wholly owned subsidiary of VIVAX BIO.spacesafetymagazine.com · bioprinting.ru · voxelmatters.directory
Research focusBiotechnology research, development of 3D bioprinters (including nozzle-free magnetic levitational bioassemblers), bio-inks, tissue engineering, regenerative medicine, organ constructs, drug discovery, disease modeling, and cellular agriculture.3dprint.com · pmc.ncbi.nlm.nih.gov · bioprinting.ru · xtalks.com
FacilityLaboratory for Biotechnological Research (Moscow, Russia).accscience.com · pmc.ncbi.nlm.nih.gov · bioprinting.ru
GrantRussian Foundation for Basic Research (RFBR) project № 18-29-11076.pmc.ncbi.nlm.nih.gov
PublicationsPeer-reviewed publications on nozzle-free magnetic levitational bioassembly, including in journals such as Biofabrication, Science Advances, and International Journal of Bioprinting.accscience.com · iopscience.iop.org · pmc.ncbi.nlm.nih.gov · bioprinting.ru
Principal staffAlexander Ostrovsky (Chairman of Supervisory Council), Yusef Hesuani (Executive Partner/Cofounder/Senior Researcher), Vladimir Mironov (Head of Research).bioprinting.ru · accscience.com

Independent sources: 3dprint.com · accscience.com · bioprinting.ru · iopscience.iop.org · pmc.ncbi.nlm.nih.gov · spacesafetymagazine.com · voxelmatters.directory · xtalks.com

Technologies
NameClusterRisk
In-space organ bioprintingcross-sector-intersectionsHigh→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.